| US 7,550,469 B2 | ||
| Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands | ||
| James A Hendrix, Hillsborough, N.J. (US); Joseph T Strupczewski, Flemington, N.J. (US); Kenneth Bordeau, Kintnersville, Pa. (US); Matthias Urmann, Eschborn (Germany); Gregory Shutske, Pittstown, N.J. (US); Horst Hemmerle, Indianapolis, Ind. (US); John G Jurcak, Bethlehem, Pa. (US); Harpal Gill, West Chester, Ohio (US); Franz J Weiberth, Ringoes, N.J. (US); Thaddeus Nieduzak, Bridgewater, N.J. (US); Sharon Anne Jackson, Whitehouse Station, N.J. (US); Xu-Yang Zhao, Bridgewater, N.J. (US); and Paul Justin Mueller, Hoboken, N.J. (US) | ||
| Assigned to Aventis Pharmaceuticals Inc., Bridgewater, N.J. (US) | ||
| Filed on Dec. 21, 2006, as Appl. No. 11/643,594. | ||
| Application 11/643594 is a continuation of application No. 10/960399, filed on Oct. 07, 2004, abandoned. | ||
| Application 10/960399 is a continuation of application No. 10/078206, filed on Feb. 19, 2002, abandoned. | ||
| Claims priority of provisional application 60/269253, filed on Feb. 16, 2001. | ||
| Claims priority of application No. 0117531.4 (GB), filed on Jul. 19, 2001. | ||
| Prior Publication US 2007/0142351 A1, Jun. 21, 2007 | ||
| Int. Cl. A61K 31/496 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01); A61K 31/4525 (2006.01); A61K 31/4535 (2006.01); A61K 31/551 (2006.01); C07D 333/66 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/041 (2006.01) | ||
| U.S. Cl. 514—254.04 [514/254.06; 540/575; 544/355; 544/357; 544/362; 544/363; 544/364; 544/370; 544/373; 544/376; 546/126; 546/198; 546/199; 546/202] | 5 Claims |
1. A compound of the formula (I):
![]() Y is carbonyl, sulfonyl, or a bond;
A is N;
n is 1;
k is 0 and the bridging bonds are absent;
x is 0, 1 or 2;
each R3 is independently hydrogen, C1-C6alkyl, or
![]() wherein w is 1, 2, or 3;
R is selected from the group consisting of (b) and (d):
![]() wherein
each Q, and V is independently hydrogen, C1-C6alkyl,
C1-C6alkoxy, halogen, trifluoromethyl or —CH2OC1-C6alkyl;
p is 0, 1 or 2;
J is hydrogen,
![]() wherein each R73 is independently hydrogen, C1-C6alkyl, halogen or trifluoromethyl and p is as hereinbefore defined;
—B— represents a group selected from groups (a) through (m):
(a) —(CH2)z— wherein z is 2, 3, 4, 5, 6 or 7;
![]() wherein
R5 and R6 are each independently hydrogen or C1-C3 linear alkyl;
R7 and R8 are each independently hydrogen or
C1-C3linear alkyl with the proviso that when R7 is
C1-C3linear alkyl, R8 cannot be C1-C3linear alkyl;
![]() wherein j is 0 or 1;
![]() wherein j is defined as above;
![]() wherein j is defined as above;
![]() wherein j is defined as above;
![]() wherein a is 0 or 1;
![]() R1 is a) hydrogen;
b) saturated or unsaturated C1-C6alkyl which is optionally mono- or di-substituted with hydroxy; or
![]() wherein
each G is independently hydrogen, C1-C6alkyl, halogen or trifluoromethyl;
each R9 and R10 is independently hydrogen or C1-C3alkyl;
t is 0 or 1; and
q is 0 or 1;
R2 is a group selected from saturated or unsaturated C1-C10alkyl, trifluoromethyl or a group selected from (a)-(ss):
![]() ![]() ![]() ![]() ![]() wherein
e is 3, 4 or 5;
y is 0, 1, or 2;
each R11 and R12 is independently hydrogen or C1-C3linear alkyl;
D is a group selected from (a) or (b):
(a) —(CR13R14)u—
wherein each R13 and R14 is independently hydrogen, halogen or C1-C3linear alkyl; and
u is 0, 1, 2 or 3;
(b) —CR15═CR16—
wherein each R15 and R16 is independently hydrogen, C1-C3linear alkyl or amino;
o is 0, 1 or 2;
M is a group selected from:
(1) hydrogen;
(2) C1-C8alkyl;
(3) C1-C6alkoxy;
(4) hydroxy;
(5) trifluoromethyl;
(6) trifluoromethoxy;
(7) —NO2;
(8) —CN;
(9) —SO2CH3;
(10) halogen;
![]() wherein each L is independently hydrogen or —NR67R68, wherein R67 and R68 are each independently hydrogen, C1-C6alkyl or
C1-C6alkoxy and o is 0, 1 or 2 as hereinbefore defined;
![]() wherein T is hydrogen or halogen and r is 0, 1, or 2;
(17)
—NR69R70
wherein R69 and R70 are each independently hydrogen or C1-C6alkyl:
(18)
—SO2NH2;
each R17 and R18 is independently hydrogen or C1-C3alkyl;
s is 0, 1 or 2;
R53 is hydrogen, halogen, hydroxy, C1-C6alkyl, amino or C1-C3alkoxy;
R54 is hydrogen, halogen, hydroxy, C1-C6alkyl, amino, —SO2NH2 or C1-C3alkoxy;
each R19 and R20 is independently hydrogen or C1-C3alkyl;
v is 0, 1 or 2;
X is O or S;
each R21 and R22 is independently hydrogen or C1-C3alkyl;
d is 0, 1 or 2;
R23 is a group selected from (a)-(h):
(a) hydrogen;
(b) C1-C6alkyl;
(c) halogen;
(d) hydroxy;
(e) C1-C3alkoxy; and
![]() wherein R24 is hydrogen or halogen;
![]() R55 is hydrogen or C1-C6alkyl;
each R25 and R26 is independently hydrogen or C1-C3alkyl;
f is 0, 1 or 2;
R27 is a group selected from (a)-(e):
(a) hydrogen;
(b) C1-C6alkyl;
(c) halogen;
(d) —SCH3; and
![]() wherein X1 is O or S and R28 is hydrogen or C1-C6alkyl;
j is 0 or 1 as hereinbefore defined;
each R56, R57 and R58 is independently hydrogen or C1-C6alkyl;
W is CH2, CH2OH or C═O;
each R29 and R30 is independently hydrogen or C1-C3alkyl;
g is 0 or 1;
X2 is O or S;
each R31 is independently hydrogen, halogen, C1-C6alkyl, trifluoromethyl, trifluoromethoxy; C1-C6alkoxy, or —NR71R72 wherein R71 and R72 are each independently hydrogen or C1-C6alkyl;
o is 0, 1 or 2 as hereinbefore defined;
R32 is hydrogen, halogen or C1-C6alkyl;
R33 is hydrogen, halogen, hydroxy, C1-C6alkyl or C1-C3alkoxy;
R34 is hydrogen, C1-C6alkyl or —CH2CO2C1-C6alkyl;
each R35 and R36 is independently hydrogen or C1-C3 linear alkyl;
h is 0 or 1;
R37 is hydrogen or C1-C6alkyl;
R41 is hydrogen, C1-C6alkyl, benzyl, acyl, tosyl, pyridyl or phenyl wherein said phenyl is optionally mono- or di-substituted with substituents
independently selected from halogen, hydroxy, C1-C6alkyl, C1-C6alkoxy and C1-C6acyl;
R59 and R60 are hydrogen, methyl or phenyl which is optionally mono- or di-substituted with substituents independently selected from halogen,
hydroxy, C1-C6alkyl, C1-C6alkoxy and C1-C6acyl;
R42 is hydrogen, C1-C6alkyl, C1-C6alkoxy, halogen, trifluoromethyl or phenoxy;
R43 is hydrogen, C1-C6alkyl or benzyl;
R61 is hydrogen or C1-C6alkyl;
R44 is hydrogen, hydroxy, C1-C6alkyl, phenyl or acyl;
R38 is hydrogen, methyl or phenyl which is optionally mono- or di-substituted with substituents independently selected from halogen,
hydroxy, C1-C6alkyl, C1-C6alkoxy and C1-C6acyl;
R45 is hydrogen, C1-C6alkyl, S—C1-C6alkyl, halogen or phenyl which is optionally mono- or di-substituted with substituents independently selected from halogen,
hydroxy, C1-C6alkyl, C1-C6alkoxy and C1-C6acyl;
R46 is hydrogen or halogen;
R62 is hydrogen, halogen or C1-C6alkyl;
R47 is SMe, SOMe or SO2Me;
R48 is hydrogen, C1-C6alkyl, trifluoromethyl, pyridyl, thiophenyl or phenyl which is optionally mono- or di-substituted with substituents independently
selected from halogen, hydroxy, C1-C6alkyl, C1-C6alkoxy and C1-C6acyl;
R63 is hydrogen or C1-C6alkyl;
R49 is methyl, trifluoromethyl, phenyl or —CH2SPh;
R50 is hydrogen, methyl, acyl or benzyl;
i is 0 or 1;
y is 0, 1 or 2 as hereinbefore defined;
p is 0, 1 or 2 as hereinbefore defined;
each R74 is independently hydrogen, C1-C6alkyl, C1-C6alkoxy or halogen;
R51 is hydrogen, hydroxy, methyl, methoxy, chlorine or —SC1-C6alkyl;
R52 is hydrogen, phenyl or thiophene;
R39 is hydrogen or C1-C6alkyl;
R40 is hydrogen, C1-C6alkyl, phenyl or benzyl;
b is 1, 2, 3 or 4;
each R64 and R65 is independently hydrogen or C1-C3alkyl;
u is 0, 1, 2, or 3 as hereinbefore defined;
each R66 is independently hydrogen, C1-C6alkyl, halogen or phenyl which is optionally mono- or di-substituted with halogen, C1-C6alkyl or trifluoromethyl;
R75 is hydrogen, halogen, C1-C6alkyl or furanyl;
c is 1 or 2;
w is 1, 2 or 3 as hereinbefore defined;
R76 is hydrogen or C1-C6alkyl;
each R77 and R78 is independently hydrogen or C1-C3alkyl;
each R79 and R80 is independently hydrogen or C1-C3alkyl;
R81 is C1-C6alkyl or phenyl optionally substituted with halogen;
each R82 and R83 is independently hydrogen or C1-C3alkyl;
R84 is hydrogen or C1-C6alkyl;
j is 0 or 1 as hereinbefore defined; and
each R85 and R86 is independently hydrogen or C1-C3alkyl and wherein a hydroxyl group or an amino group can be acylated with (C4-C18)alkanoyl group or a (C4-C18)alkoxycarbonyl group.
|